Related Experiment Video
Updated: May 16, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Prognostic stratification by conventional echocardiography of patients with aortic stenosis: the "CAIMAN-ECHO score"
Giovanni Cioffi1, Carmine Mazzone, Pompilio Faggiano
1Department of Cardiology, Villa Bianca Hospital, Trento, Italy. gcioffi@villabiancatrento.it
Insights
A new CAIMAN-ECHO score accurately stratifies risk in asymptomatic aortic stenosis (AS) patients. This simple tool aids in predicting cardiovascular events for better management of moderate-to-severe AS.
Area of Science:
- Cardiology
- Echocardiography
- Cardiovascular Medicine
Background:
- Asymptomatic aortic stenosis (AS) management requires risk stratification.
- Prognosis in asymptomatic AS patients can be worse than anticipated.
- Current guidelines do not recommend surgery for asymptomatic AS patients.
Purpose of the Study:
- To develop and validate a simple score, CAIMAN-ECHO, for risk stratification in asymptomatic moderate-to-severe AS.
- To identify key echocardiographic parameters predicting cardiovascular events.
- To improve prognostic accuracy for asymptomatic AS patients.
Main Methods:
- Analysis of 141 patients with moderate-to-severe AS followed for 36 months.
- Defined endpoint: all-cause death, symptom-driven aortic valve replacement, or hospital admission for myocardial infarction/heart failure.
- Validated the score in a prospective cohort of 143 patients.
Main Results:
- Higher aortic transvalvular peak jet velocity, calcium score, and observed/predicted left ventricular (LV) mass ratio were associated with adverse events.
- Developed the CAIMAN-ECHO score based on these parameters.
- Event-free survival varied significantly across score quartiles (18% to 96%), with 84% and 77% prediction accuracy in original and validation cohorts.
Conclusions:
- The CAIMAN-ECHO score is a simple and feasible tool.
- It provides accurate prognostic stratification for asymptomatic moderate-to-severe AS patients.
- Facilitates better clinical decision-making in this patient group.
Background And Aim:
Surgery is not recommended in asymptomatic patients with aortic stenosis (AS). However, prognosis of these patients is worse than retained. We built a simple score (named by the acronym "CAIMAN") for stratifying asymptomatic patients with AS according to the different risk for cardiovascular events.
Material And Methods:
Data from 141 patients with moderate-to-severe AS followed up for 36 months were analyzed. The end point "outcome" was defined as death of all causes or aortic valve replacement imposed by symptoms or hospital admission for myocardial infarction and/or heart failure. The score was validated in 143 patients prospectively recruited in 2 different centers.
Results:
The 40 events occurred in the original cohort were associated with higher aortic transvalvular peak jet velocity, calcium score, and observed/predicted left ventricular (LV) mass ratio. Based on the hazard ratios of Cox analysis, the score was calculated as follows: calcium score 1-3 = 1 point, 4 = 6 points; transvalvular peak jet velocity ≤3.6 m/sec = 1 point, 3.6 m/sec = 3 points, observed/predicted LV mass ratio ≤110% = 1 point, >110% = 3 points. After a mean period of 28 ± 18 months, event-free survival was 18%, 42%, 91%, and 96% in the 4 quartiles of echo score. The accuracy of the score in predicting events was 84% and 77% (P = 0.09) in the original and validation cohort, respectively.
Conclusions:
The CAIMAN-ECHO score is a simple and feasible tool useful for an accurate prognostic stratification of patients with asymptomatic moderate-to-severe AS.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Heart Failure IV: Classification and Diagnostic Evaluation
Aneurysm II: Clinical Manifestations and Diagnostic Studies
